Dr. Joseph McConnell Presents Lipoprotein (a), an Inflammatory Lipoprotein at National Lipid Association Summer Clinical Update
For Immediate Release
September 30, 2010
Richmond, Virginia — Dr. Joseph McConnell, Chief Medical Officer at Health Diagnostic Laboratory Inc. (HDL, Inc.), www.myhdl.com, presented Lipoprotein (a), an Inflammatory Lipoprotein: Recent Findings Including a Better Approach to Measurement, at the National Lipid Association (NLA) Summer Clinical Update on August 28, 2010. Dr. McConnell, who was formerly the Director of Cardiovascular Laboratory Medicine in the Department of Laboratory Medicine at Mayo Clinic, is a co-founder of Health Diagnostic Laboratory, a new clinical laboratory focused on fighting the alarming increase in chronic disease.
Participants of the NLA Summer Clinical Lipid Update were invited to join Dr. McConnell and other medical leaders for the innovation lab focused on finding a better approach to measurement. Dr. McConnell explored both Lipoprotein (a) as well as spent time with the audience during a cocktail reception featuring heart healthy cuisine, fine wines, and a signature HDL, Inc. cocktail (called the “lipid-tini”) served in the Rhode Island Room at the Renaissance Mayflower Hotel in Washington, D.C.
Dr. McConnell was formally the Chair of the Clinical Chemistry Fellowship Program and the Medical Director of the Clinical Laboratory Sciences Program at the Mayo Clinic. He held a joint appointment in the Cardiovascular Diseases Section of the Division of Internal Medicine at the Mayo Clinic. Dr. McConnell’s primary research interest is in the field of atherosclerosis, specifically the use of novel risk factors to identify subjects at increased risk for developing cardiovascular disease and events with a focus on prevention. He has co-authored over 80 manuscripts in peer-reviewed, scientific literature on topics in cardiovascular disease and risk management.
Health Diagnostic Laboratory, Inc., located at the Virginia BioTechnology Research Park, is changing the way clinical laboratories interact with physicians and patients. The professionals at HDL, Inc., such as Dr. McConnell, partner with clients to provide the most advanced practices for diagnosis and treatment of cardiovascular and related chronic diseases. The award-winning laboratory offers a comprehensive panel of tests to help physicians personalize treatment based on more complete patient profiling. The result — earlier detection of risk factors pre-disposing patients to disease, more advanced evidence-based treatments, and fewer patients progressing to overt disease.
In addition to the filled-to-capacity presentation by Dr. McConnell, HDL, Inc. served as a major sponsor of the National Lipid Association.
About Health Diagnostic Laboratory, Inc. : www.myhdl.com
About the Virginia BioTechnology Research Park: The Virginia BioTechnology Research Park is currently home to a unique mix of more than 58 public and private bioscience companies, research institutes affiliated with the VCU Medical Center, and major state and national medical laboratories. These companies are housed in nine buildings totaling more than 1.1 million square feet of space, representing an employee base that exceeds 2,000. The Park’s Biosciences Commercialization Center has been created to take incubator graduates through commercialization to M&A or IPO, giving the Park’s tenants full-scale business assistance. The Commercialization Center is now the home of twelve companies from the Israeli life science community and continues to expand its resource base. It has created alliances with leading incubators in Israel. To date, the Park’s incubator and commercialization center have graduated three companies that are now publicly traded. www.vabiotech.com.
Contact:
Paul Spicer
Director of Public Relations and Marketing
Health Diagnostic Laboratory, Inc.
Phone: (804) 343-2713
Email: PSpicer@hdlabinc.com
Courtney Skunda
Marketing and Communications Manager
Virginia BioTechnology Research Park
Phone: (804) 827-2137
Email: cskunda@vabiotech.com
